Besides CTLA-4, now several immune checkpoint receptors (ICRs), such as PD‐1, LAG3, TIM-3, B7‐H3, and diacylglycerol kinase α, have been also identified to treat cancer patients effectively [24, 25]. This evidence concerns the gene CTLA4 and cancer.